Today's Paper Latest stories Weather Obits Newsletters Puzzles/games
ADVERTISEMENT
ADVERTISEMENT
story.lead_photo.caption Dr. Gareth Morgan (center) was named the director of the University of Arkansas for Medical Sciences Myeloma Institute for Research and Therapy on Tuesday morning. He succeeds Dr. Bart Barlogie, the institute's founder. - Photo by Lisa Burnett

UAMS names Gareth Morgan director of Myeloma Institute

UAMS officials announced Tuesday that Dr. Gareth Morgan will succeed Dr. Bart Barlogie as the director of the UAMS Myeloma Institute. He will start as director on July 1. (By Lisa Burnett)
[View Full-Size]

LITTLE ROCK — A London doctor has been tapped to serve as the new director for a cancer center at the University of Arkansas for Medical Sciences in Little Rock.

UAMS officials announced Tuesday that Dr. Gareth Morgan would succeed Dr. Bart Barlogie as the leader for UAMS' Myeloma Institute for Research and Therapy.

"Dr. Barlogie has chosen to step down as institute director, but he has not chosen to step down from his professional endeavors in the treatment and research and causes and better approaches to the disease for individuals with myeloma. He will continue his focus on patient care and research," UAMS Chancellor Dr. Dan Rahn said Tuesday.

Barlogie was the founder and director for the center that was established nearly 25 years ago to research and offer clinical care of multiple myeloma, a rare form of bone marrow cancer. More than 11,000 patients nationwide and from around the world have sought treatment at the myeloma institute.

Morgan will assume the duties of director on July 1.

"I'm really looking forward to arriving in Arkansas. It's a great opportunity for me. It's an opportunity for the institution, but most of all, it's an opportunity for the patients," he said.

Before taking the UAMS job, Morgan served as a professor of hematology and director of the Centre for Myeloma Research at the Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London, a UAMS news release states.

"It took a lot to drag me out of London," Morgan said. "There's no doubt that Bart's done great things here with the staff. [UAMS Myeloma Institute] is definitely the world's premium myeloma center."

Morgan plans to bring some new staff on board when he gets started, but he said he wasn't sure when.

Meanwhile, UAMS officials said the myeloma institute has received about $20 million in state funding and philanthropic contributions.

In an announcement Tuesday, UAMS officials said the funding will help pay for new laboratory construction and research programs by the Myeloma Institute for Research and Therapy. They say the myeloma institute received about $5 million from the state's General Improvement Funds, which was matched 3-to-1 by philanthropic contributions.

The first matching gift was $5 million and was made by the Goldman Sachs Philanthropy Fund.

Information for this article was contributed by The Associated Press and by Lisa Burnett of Arkansas Online.

Sponsor Content

Comments

You must be signed in to post comments
  • the1andonly
    April 23, 2014 at 5:37 a.m.

    Looks like Dr. Barlogie's alcoholism and pi$$ poor clinical practices got him fired, he did not choose to step down. Wonder if UAMS got investigated for his Medicare fraud? OR was it the nursing board investigation of his nurse that was practicing since 2009 without a nursing license? OR was this the only way Dr. Rahn could get ol Bart to quit smoking on campus? I guess it is time to get rid of some trash up there at UAMS

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT